Ro
The patient-driven healthcare company for GLP-1 weight loss
Our Rating
Embed This Rating
Are you the owner of Ro? Add your PepsReview rating badge to your website in under 2 minutes. Free, no signup required.
About Ro
Major direct-to-consumer telehealth company offering weight-loss programs including compounded semaglutide and tirzepatide through the Ro Body Program with physician consultation and partner pharmacies.
Score Breakdown
Pros & Cons
Pros
- Well-funded legitimate telehealth company with real physicians
- Smooth app experience end-to-end
- 2-day shipping from partner pharmacies
- Regular doctor follow-ups and dose adjustments
- Strong brand trust and high public visibility
Cons
- Expensive at $145/month for GLP-1 program
- No insurance accepted for compounded versions
- Compounded semaglutide availability depends on FDA shortage status
- No published COAs
- Not a research peptide vendor
Reviews
I've been on the Ro Body Program for 3 months now. The app experience is smooth — video consultation, prescription, delivery all in one platform. Compounded semaglutide arrived in 2 days from their partner pharmacy. Lost 18 lbs so far. The downside is cost — $145/month plus the initial consultation. No insurance coverage. But the convenience and medical oversight are real.
Tried Henry Meds first and had a terrible experience. Switched to Ro and the difference is night and day. The doctor actually listened, adjusted my tirzepatide dose based on side effects, and checked in regularly. Medication shipped fast with proper cold-chain packaging. The app tracks everything — weight, side effects, dosing schedule. Worth the premium for the quality of care.
Ro does everything right in terms of process — consultation, prescription, shipping, follow-up. The compounded semaglutide is effective. But at $145/month it's not sustainable for many people. Also they don't accept insurance for the compounded version. If money isn't an issue, this is a premium option. For budget-conscious users, there are cheaper telehealth alternatives.